Navigation Links
New probe to detect skin cancer receives more funding for clinical trials
Date:8/18/2008

AUSTIN, TexasAssistant Professor James Tunnell has been awarded a Phase II Early Career Award from the Wallace H. Coulter Foundation to continue the development and testing of a device that uses light to detect skin cancer without the need for an invasive biopsy procedure.

The $260,000 grant will support Tunnell's work for the next two years to refine the device called a "clinical spectrometer" and to conduct additional clinical trials. He previously received one of 23 Phase I awards from the foundation, and was one of seven Phase II awards selected from that pool to continue his research.

Using a pen-sized probe, weak pulses of light are emitted from the tip onto the skin or tissue and then recaptured by the probe and sent back to a computer system for analysis.

"Within a second, it can take a measurement and tell you whether or not its cancer," says Tunnell, a biomedical engineer at The University of Texas at Austin. "And you can move the probe around quickly to different spots of the skin."

The light measures the cellular and molecular signatures of skin cancer without the need for a biopsy or the excision of a tissue sample.

"It can tell if the structures of the cells and the biochemicals present are associated with the progression of these cancers," Tunnell says. "Many biopsies and surgeries would be unnecessary if you had a device that could catch the cancer earlier and identify the margins of where it exists."

Skin cancer is the most common cancer globally. In the United States, more than one million new cases occur annually, according to the National Cancer Institute.

So far, the device has been tested on 80 people in clinical trials at M.D. Anderson Cancer Center in Houston and with The University of Texas Medical Branch clinicians in Austin. A total of 300 people will be screened at those institutions using the device.

"The early results look very promising," Tunnell says.

The fiber probe, he says, is small enough to fit inside an endoscope, making it adaptable to also detect esophageal cancer. Tunnell says it could take three to five years for commercialization if it's deemed commercially viable.

Collaborators on the project include: Tri Nguyen, director of the Mohs Micrograph and Dermatologic Surgery Clinic at M.D. Anderson, and Jason Riechenberg, clinical director for dermatology at The University of Texas Medical Branch.


'/>"/>

Contact: James Tunnell
jtunnell@mail.utexas.edu
512-232-2110
University of Texas at Austin
Source:Eurekalert

Related medicine news :

1. Study Probes Internet Health-Related Search Patterns
2. String probes for devastating childhood digestive disease
3. Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans
4. Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber
5. Kings County Death: NAMI Calls for Criminal Probe; Survey Shows Psychiatric Emergency Room Delays Are National Problem
6. Laser surgery probe targets individual cancer cells
7. FDA Narrowing Tainted Tomato Probe to One Cluster
8. Gen-Probe to Webcast Two Upcoming Investor Presentations
9. Type of anesthetic will improve sleeping medication, probe mysteries of the snooze
10. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
11. Matrix registry probes adherence to clopidogrel at 1 year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could ... after surgery, though activity levels decline over time. The study, presented today at ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... why concussion rates are on the rise, say researchers presenting their work at ... Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change in ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
(Date:7/20/2017)... NY, July 20, 2017 (PRWEB) , ... ... ... Nastel Technologies, a global provider of enterprise-grade IT operations analytics and application ... arm of one of world’s largest healthcare services providers. , According to ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of oral ... from the Israel Securities Authority to dual-list its common stock ... will commence trading on the TASE on July 12, 2017 ... of the Company, it is expected that Oramed will be ...
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
(Date:6/30/2017)... In vitro diagnostics market firm Kalorama Information ... least ten diagnostic companies have successfully completed financings.  The ... a loan facility.  The size of these financings ranged ... Information provides a monthly IVD Market Trends Report ... "Diagnostics deals ...
Breaking Medicine Technology: